These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3088133)

  • 21. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
    Mitsuhashi S
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical perspectives on imipenem.
    Neu HC
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():149-53. PubMed ID: 6583196
    [No Abstract]   [Full Text] [Related]  

  • 24. beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
    Godfrey AJ; Bryan LE; Rabin HR
    Antimicrob Agents Chemother; 1981 May; 19(5):705-11. PubMed ID: 6457554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbenicillin resistance of Pseudomonas aeruginosa.
    Rodríguez-Tebar A; Rojo F; Dámaso D; Vázquez D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):255-61. PubMed ID: 6821456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5.
    Livermore DM
    J Antimicrob Chemother; 1987 Jun; 19(6):733-42. PubMed ID: 3112099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activity of CGP 31608, a new penem.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli.
    Hashizume T; Ishino F; Nakagawa J; Tamaki S; Matsuhashi M
    J Antibiot (Tokyo); 1984 Apr; 37(4):394-400. PubMed ID: 6427167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    Sumita Y; Fukasawa M
    J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 Mar; 43(3):314-20. PubMed ID: 2108953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.
    Parr TR; Bryan LE
    Antimicrob Agents Chemother; 1984 Jun; 25(6):747-53. PubMed ID: 6611136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
    Lessel J
    Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillin-binding proteins of Thiobacillus versutus.
    Markiewicz Z; Baj J; Włodarczyk M
    Acta Microbiol Pol; 1985; 34(2):103-10. PubMed ID: 2412397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Büscher KH; Cullmann W; Dick W; Opferkuch W
    Antimicrob Agents Chemother; 1987 May; 31(5):703-8. PubMed ID: 3111361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.